Dr. Peter Shalit, MD ( Site 2770)

Seattle, Washington 98104

0 studies enrolling now · 1 studies all time

What they study most

HIV Infection

Studies at this site

• Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018) — Completed